Evidence map›Paper›PMID 34170444›Full record

ArticleClinical rheumatology2021

Development of an Arabic version of the Behçet's Disease Current Activity Form (Ar-BDCAF): cross-cultural adaptation and validation initiative in Egypt.

Tamer A Gheita, Hanan M Fathi, Nahla N Eesa, Emad El-Shebini, Samar Tharwat, Nevin Hammam, Rasha M Fawzy, Rawhya R El-Shereef, Mona H Abd El-Samea, Rasha A Abdel Noor and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 2 countries.

Tamer A GheitaRheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. gheitamer@hotmail.com.ORCID http://orcid.org/0000-0002-1155-9729
Hanan M FathiRheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Nahla N EesaRheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Emad El-ShebiniInternal Medicine Department, Rheumatology Unit, Menoufia University, Menoufia, Egypt.
Samar TharwatRheumatology and Immunology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Nevin HammamDivision of Rheumatology, Department of Medicine, University of California, San Francisco, CA, USA.
Rasha M FawzyRheumatology Department, Faculty of Medicine, Benha University, Benha, Egypt.
Rawhya R El-ShereefRheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt.
Mona H Abd El-SameaRheumatology Department, Faculty of Medicine, Assuit University, Assuit, Egypt.
Rasha A Abdel NoorInternal Medicine Department, Rheumatology Unit, Tanta University, Gharbia, Egypt.
Mohamed N SalemInternal Medicine Department, Rheumatology Immunology Division, Beni-Suef University, Beni-Suef, Egypt.
Egyptian College of Rheumatology Study Group
Benha University · EGBeni-Suef University · EGCairo University · EGFayoum University · EGAssiut University · EGMansoura University · EGMenoufia University · EGMinia University · EGTanta University Hospital · EGUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBehçet's disease (BD), commonly seen in the Silk road countries, is a variable vessel vasculitis with no specific investigation that reflects disease activity. The Behçet's Disease Current Activity Form (BDCAF) is the most famous and acceptable clinical activity score. PURPOSE: To develop a cross-cultural adaptation of the BDCAF to the Arabic language (Ar-BDCAF)-Egyptian dialect-across the country and to consider preliminary evaluation of its reliability in assessment of BD activity. PATIENTS AND

methodsThe score was translated to Arabic language and revised by 3 rheumatology consultants. Reliability of Ar-BDCAF was tested among 88 BD patients from 9 Egyptian main city centers. Patients were questioned by two specialists at 30 min interval to evaluate inter-observer rating and twice by the same physician within 24 h to assess the intra-observer rating.

resultsPatients were 64 males and 24 females (2.7:1) with a mean age of 35 ± 10.3 years. The average time required by the consultant to fill in the form was 5.1 ± 2.2 min (1.5-15 min). The mean Ar-BDCAF scores were 9.81 ± 6.22 (0-25) and 9.53 ± 6.13 (0-28) with an intra-observer concordance (p = 0.28) and was 9.95 ± 6.47 (0-29) for the inter-observer rating (p = 0.89 and p = 0.66, respectively).

conclusionThe Ar-BDCAF is a measurable, easy to calculate, and reliable index for assessing disease activity in Egyptian BD. The Ar-BDCAF score can be used in daily clinical practice to assess BD activity and its use can be extended to other Arab countries for possible regional validation and adaptations. Key Points • The Arabic version of the BDCAF can be extended to other Arab countries for development of a Pan-Arab score. • This is the first study to provide a reliable and valid Arabic version of the BDCAF-Egyptian dialect for measuring current disease activity in BD patients.

Indexed as

Behcet SyndromeLanguageAdultCross-Cultural ComparisonEgyptFemaleHumansMaleMiddle AgedReproducibility of ResultsSeverity of Illness IndexSurveys and QuestionnairesYoung AdultActivityArabicBehçet’s diseaseCross-culturalReliabilityValidity

Identifiers

PMID34170444
OpenAlexW3176827224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.